Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C.

about

SB 9200, a novel agonist of innate immunity, shows potent antiviral activity against resistant HCV variants.Sofosbuvir/Velpatasvir/Voxilaprevir: A Pan-Genotypic Direct-Acting Antiviral Combination for Hepatitis C.

P2860

Q38902034-77AAC981-225F-4033-B6D3-34181EB3883D Q47587210-8AE312F5-54EF-43B5-A6EB-6D9ABEDECECB

P2860

Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C.

Item

http://www.wikidata.org/entity/Q38949900

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Sofosbuvir/Velpatasvir: The Fi ...... l Combination for Hepatitis C.

@en

type

Item

label

Sofosbuvir/Velpatasvir: The Fi ...... l Combination for Hepatitis C.

@en

prefLabel

Sofosbuvir/Velpatasvir: The Fi ...... l Combination for Hepatitis C.

@en

P1476

Sofosbuvir/Velpatasvir: The Fi ...... l Combination for Hepatitis C.

@en

P2093

Allana J Sucher

http://www.w3.org/2001/XMLSchema#string

Brian A Hemstreet

http://www.w3.org/2001/XMLSchema#string

Elias B Chahine

http://www.w3.org/2001/XMLSchema#string

P2860

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Liver transplantation for viral hepatitis in 2015

Involvement of hepatitis C virus NS5A hyperphosphorylation mediated by casein kinase I-α in infectious virus production.

Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource

Global distribution and prevalence of hepatitis C virus genotypes.

Pharmacokinetic, Pharmacodynamic, and Drug-Interaction Profile of the Hepatitis C Virus NS5B Polymerase Inhibitor Sofosbuvir.

Antiviral activity and resistance of HCV NS5A replication complex inhibitors.

Treatment of a patient with genotype 7 hepatitis C virus infection with sofosbuvir and velpatasvir.

Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.

Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.

P31

scholarly article

P356

10.1177/1060028016668897

http://www.w3.org/2001/XMLSchema#string

P407

English

P577

2016-09-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27609942

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C.

about

P2860

P2860

Sofosbuvir/Velpatasvir: The First Pangenotypic Direct-Acting Antiviral Combination for Hepatitis C.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P577

P698

P921